2016 annual financial data
BioCryst Pharmaceuticals 2016 Operating margin
Direct answer
Operating margin was -184.45%.
Operating income was -48,607,000 USD and net income was -55,144,000 USD.
Operating cash flow was -53,438,000 USD.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,353,000 USD
- Operating income
- -48,607,000 USD
- Net income
- -55,144,000 USD
- Operating cash flow
- -53,438,000 USD